I joined Ingenza in 2009 as a graduate in biomedical sciences. Five years later, with some industrial experience behind me, I decided that I would like to do a PhD, ideally while continuing to work at Ingenza. However, although there…
Biopharmaceuticals now account for a significant proportion of new drugs being released onto the market, providing alternative treatment strategies for many medical conditions, as well as offering new hope for previously untreatable or orphan diseases. Unlike the manufacture of small…
Scotland leads the way in the UK for environmental and agricultural biotech start-ups and, as a biotech company, it’s important for us to be actively involved in this community. The Industrial Biotechnology Innovation Centre (IBioIC20) Annual Conference is perfect for…
Ingenza’s Dr Stephen McColm is celebrating success after being awarded a PhD in chemistry from the University of Edinburgh. Through an 1851 Royal Commission Fellowship, a scheme that funds innovative doctoral research with commercial potential, Stephen developed an enhanced DNA…
Most days start the same for me – being rudely awoken at 6 am by an impatient toddler demanding a bowl of Shreddies. After the inevitable cereal explosion has been contained and the ensuing struggle to brush teeth is complete,…
Although it has only been three years since I joined Ingenza, I have witnessed many significant changes in the way our company functions. Our move to the Roslin Innovation Centre has, of course, changed almost every aspect of our daily…
Amprologix, Executive Management team, Dr Gordon Barker, Professor Mathew Upton and Dr Ian Fotheringham. Ingenza is pleased to announce that University of Plymouth spin-out Amprologix, in which it has a stake, has been awarded a £1.2 million contract from the…
Ingenza is proud to announce that Managing Director Ian Fotheringham has been recognised with one of SCI Scotland’s most prestigious honours – the Charles Tennant Memorial Lecture award – acknowledging his expertise and knowledge in chemical research. SCI is a…
Ingenza, a leading industrial biotech company, is pleased to announce that Syngenta is exercising its commercial licensing option for a technology that enables the development of innovative crop protection products. This enabling technology – the result of an initial collaboration…
Ingenza colleague, Jack Kay, has been recognised by Life Sciences Scotland as their Rising Star for November 2018. Read more about Jack’s development and progression at Ingenza over the years on the Life Sciences Scotland website; https://www.lifesciencesscotland.com/rising-stars/novembers-rising-star-jack-kay